Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_assertion type Assertion NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_head.
- NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_assertion description "[HLA-DR4 is associated with a diminished risk of the development of chronic myeloid leukemia (CML). Chronic Leukemia Working Party of the European Blood and Marrow Transplant Registry.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_provenance.
- NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_assertion evidence source_evidence_literature NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_provenance.
- NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_assertion SIO_000772 10803518 NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_provenance.
- NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_assertion wasDerivedFrom befree-20140225 NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_provenance.
- NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_assertion wasGeneratedBy ECO_0000203 NP922635.RAH-Y_0LI4qFptWzzQmHtNHiVpBrWWhVUsvKLegyG-JTs130_provenance.